Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL Read more
Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection Read more
Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes Read more
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData Read more